Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 13, 2005
Stem Cells Vol. 23 No. 8 September 2005, pp. 1200 -1211
doi:10.1634/stemcells.2004-0303; www.StemCells.com
© 2005 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0303v1
23/8/1200    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dvorak, P.
Right arrow Articles by Hampl, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dvorak, P.
Right arrow Articles by Hampl, A.

Expression and Potential Role of Fibroblast Growth Factor 2 and Its Receptors in Human Embryonic Stem Cells

Petr Dvoraka,c,d, Dana Dvorakovab, Stanislava Koskovaa, Martina Vodinskaa, Miroslava Najvirtovad, Daniel Krekaca,c, Ales Hampla,c,d

a Department of Molecular Embryology, Institute of Experimental Medicine AS CR, Brno, Czech Republic;
b Department of Internal Medicine, Hematooncology, University Hospital Brno, Brno, Czech Republic;
c Laboratory of Molecular Embryology, Mendel University Brno, Brno, Czech Republic;
d Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic

Key Words. Growth factor • Human embryonic stem cells • Cell signaling • Differentiation

Correspondence: Petr Dvorak, Ph.D., Laboratory of Molecular Embryology, Mendel University, Brno Zemedelska 1, 613 00 Brno, Czech Republic. Telephone: 420-5-45133298; Fax: 420-5-45133357; e-mail: dvorakp{at}mendelu.cz

Although the detection of several components of the fibroblast growth factor (FGF) signaling pathway in human embryonic stem cells (hESCs) has been reported, the functionality of that pathway and effects on cell fate decisions are yet to be established. In this study we characterized expression of FGF-2, the prototypic member of the FGF family, and its receptors (FGFRs) in undifferentiated and differentiating hESCs; subsequently, we analyzed the effects of FGF-2 on hESCs, acting as both exogenous and endogenous factors. We have determined that undifferentiated hESCs are abundant in several molecular-mass isoforms of FGF-2 and that expression pattern of these isoforms remains unchanged under conditions that induce hESC differentiation. Significantly, FGF-2 is released by hESCs into the medium, suggesting an autocrine activity. Expression of FGFRs in undifferentiated hESCs follows a specific pattern, with FGFR1 being the most abundant species and other receptors showing lower expression in the following order: FGFR1 -> FGFR3 -> FGFR4 -> FGFR2. Initiation of differentiation is accompanied by profound changes in FGFR expression, particularly the upregulation of FGFR1. When hESCs are exposed to exogenous FGF-2, extracellular signal-regulated kinases are phosphorylated and thereby activated. However, the presence or absence of exogenous FGF-2 does not significantly affect the proliferation of hESCs. Instead, increased concentration of exogenous FGF-2 leads to reduced outgrowth of hESC colonies with time in culture. Finally, the inhibitor of FGFRs, SU5402, was used to ascertain whether FGF-2 that is released by hESCs exerts its activities via autocrine pathways. Strikingly, the resultant inhibition of FGFR suppresses activation of downstream protein kinases and causes rapid cell differentiation, suggesting an involvement of autocrine FGF signals in the maintenance of proliferating hESCs in the undifferentiated state. In conclusion from our data, we propose that this endogenous FGF signaling pathway can be implicated in self-renewal or differentiation of hESCs.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. K. Furue, J. Na, J. P. Jackson, T. Okamoto, M. Jones, D. Baker, R.-I. Hata, H. D. Moore, J. D. Sato, and P. W. Andrews
Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium
PNAS, September 9, 2008; 105(36): 13409 - 13414.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. Yu and J. A. Thomson
Pluripotent stem cell lines
Genes & Dev., August 1, 2008; 22(15): 1987 - 1997.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Mayshar, E. Rom, I. Chumakov, A. Kronman, A. Yayon, and N. Benvenisty
Fibroblast Growth Factor 4 and Its Novel Splice Isoform Have Opposing Effects on the Maintenance of Human Embryonic Stem Cell Self-Renewal
Stem Cells, March 1, 2008; 26(3): 767 - 774.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
M. J. Go, C. Takenaka, and H. Ohgushi
Effect of Forced Expression of Basic Fibroblast Growth Factor in Human Bone Marrow-Derived Mesenchymal Stromal Cells
J. Biochem., December 1, 2007; 142(6): 741 - 748.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Wang, T. C. Schulz, E. S. Sherrer, D. S. Dauphin, S. Shin, A. M. Nelson, C. B. Ware, M. Zhan, C.-Z. Song, X. Chen, et al.
Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling
Blood, December 1, 2007; 110(12): 4111 - 4119.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Greber, H. Lehrach, and J. Adjaye
Fibroblast Growth Factor 2 Modulates Transforming Growth Factor {beta} Signaling in Mouse Embryonic Fibroblasts and Human ESCs (hESCs) to Support hESC Self-Renewal
Stem Cells, February 1, 2007; 25(2): 455 - 464.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
Y. Babaie, R. Herwig, B. Greber, T. C. Brink, W. Wruck, D. Groth, H. Lehrach, T. Burdon, and J. Adjaye
Analysis of Oct4-Dependent Transcriptional Networks Regulating Self-Renewal and Pluripotency in Human Embryonic Stem Cells
Stem Cells, February 1, 2007; 25(2): 500 - 510.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Timmer, K. Cesnulevicius, C. Winkler, J. Kolb, E. Lipokatic-Takacs, J. Jungnickel, and C. Grothe
Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion
J. Neurosci., January 17, 2007; 27(3): 459 - 471.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L.-E. Zaragosi, G. Ailhaud, and C. Dani
Autocrine Fibroblast Growth Factor 2 Signaling Is Critical for Self-Renewal of Human Multipotent Adipose-Derived Stem Cells
Stem Cells, November 1, 2006; 24(11): 2412 - 2419.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al.
The role of PI3K/AKT, MAPK/ERK and NF{kappa}{beta} signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis
Hum. Mol. Genet., June 1, 2006; 15(11): 1894 - 1913.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. Koellensperger, D. von Heimburg, M. Markowicz, and N. Pallua
Human Serum from Platelet-Poor Plasma for the Culture of Primary Human Preadipocytes
Stem Cells, May 1, 2006; 24(5): 1218 - 1225.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Yu, M. A. Vodyanik, P. He, I. I. Slukvin, and J. A. Thomson
Human Embryonic Stem Cells Reprogram Myeloid Precursors Following Cell-Cell Fusion
Stem Cells, January 1, 2006; 24(1): 168 - 176.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 2005 by AlphaMed Press.